TY - JOUR AU - Davies, H. AU - Bignell, G. R. AU - Cox, C. AU - Stephens, P. AU - Edkins, S. AU - Clegg, S. PY - 2002 DA - 2002// TI - Mutations of the BRAF gene in human cancer JO - Nature VL - 417 UR - https://doi.org/10.1038/nature00766 DO - 10.1038/nature00766 ID - Davies2002 ER - TY - JOUR AU - Pollock, P. M. AU - Harper, U. L. AU - Hansen, K. S. AU - Yudt, L. M. AU - Stark, M. AU - Robbins, C. M. PY - 2003 DA - 2003// TI - High frequency of BRAF mutations in nevi JO - Nat Genet VL - 33 UR - https://doi.org/10.1038/ng1054 DO - 10.1038/ng1054 ID - Pollock2003 ER - TY - JOUR AU - Guan, J. AU - Gupta, R. AU - Filipp, F. V. PY - 2015 DA - 2015// TI - Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma JO - Sci Rep VL - 5 UR - https://doi.org/10.1038/srep07857 DO - 10.1038/srep07857 ID - Guan2015 ER - TY - JOUR AU - Tsai, J. AU - Lee, J. T. AU - Wang, W. AU - Zhang, J. AU - Cho, H. AU - Mamo, S. PY - 2008 DA - 2008// TI - Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity JO - Proc Natl Acad Sci U S A VL - 105 UR - https://doi.org/10.1073/pnas.0711741105 DO - 10.1073/pnas.0711741105 ID - Tsai2008 ER - TY - JOUR AU - Chapman, P. B. AU - Hauschild, A. AU - Robert, C. AU - Haanen, J. B. AU - Ascierto, P. AU - Larkin, J. PY - 2011 DA - 2011// TI - Improved survival with vemurafenib in melanoma with BRAF V600E mutation JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1103782 DO - 10.1056/NEJMoa1103782 ID - Chapman2011 ER - TY - JOUR AU - Flaherty, K. T. AU - Robert, C. AU - Hersey, P. AU - Nathan, P. AU - Garbe, C. AU - Milhem, M. PY - 2012 DA - 2012// TI - Improved survival with MEK inhibition in BRAF-mutated melanoma JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1203421 DO - 10.1056/NEJMoa1203421 ID - Flaherty2012 ER - TY - JOUR AU - Flaherty, K. T. AU - Infante, J. R. AU - Daud, A. AU - Gonzalez, R. AU - Kefford, R. F. AU - Sosman, J. PY - 2012 DA - 2012// TI - Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1210093 DO - 10.1056/NEJMoa1210093 ID - Flaherty2012 ER - TY - JOUR AU - Robert, C. AU - Karaszewska, B. AU - Schachter, J. AU - Rutkowski, P. AU - Mackiewicz, A. AU - Stroiakovski, D. PY - 2015 DA - 2015// TI - Improved overall survival in melanoma with combined dabrafenib and trametinib JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1412690 DO - 10.1056/NEJMoa1412690 ID - Robert2015 ER - TY - JOUR AU - Long, G. V. AU - Stroyakovskiy, D. AU - Gogas, H. AU - Levchenko, E. AU - de Braud, F. AU - Larkin, J. PY - 2014 DA - 2014// TI - Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1406037 DO - 10.1056/NEJMoa1406037 ID - Long2014 ER - TY - JOUR AU - Cheng, Y. AU - Zhang, G. AU - Li, G. PY - 2013 DA - 2013// TI - Targeting MAPK pathway in melanoma therapy JO - Cancer Metastasis Rev VL - 32 UR - https://doi.org/10.1007/s10555-013-9433-9 DO - 10.1007/s10555-013-9433-9 ID - Cheng2013 ER - TY - JOUR AU - Nazarian, R. AU - Shi, H. AU - Wang, Q. AU - Kong, X. AU - Koya, R. C. AU - Lee, H. PY - 2010 DA - 2010// TI - Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation JO - Nature VL - 468 UR - https://doi.org/10.1038/nature09626 DO - 10.1038/nature09626 ID - Nazarian2010 ER - TY - JOUR AU - Wagle, N. AU - Emery, C. AU - Berger, M. F. AU - Davis, M. J. AU - Sawyer, A. AU - Pochanard, P. PY - 2011 DA - 2011// TI - Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.2312 DO - 10.1200/JCO.2010.33.2312 ID - Wagle2011 ER - TY - JOUR AU - Poulikakos, P. I. AU - Persaud, Y. AU - Janakiraman, M. AU - Kong, X. AU - Ng, C. AU - Moriceau, G. PY - 2011 DA - 2011// TI - RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E) JO - Nature VL - 480 UR - https://doi.org/10.1038/nature10662 DO - 10.1038/nature10662 ID - Poulikakos2011 ER - TY - JOUR AU - Van Allen, E. M. AU - Wagle, N. AU - Sucker, A. AU - Treacy, D. J. AU - Johannessen, C. M. AU - Goetz, E. M. PY - 2014 DA - 2014// TI - The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma JO - Cancer Discov. VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0617 DO - 10.1158/2159-8290.CD-13-0617 ID - Van Allen2014 ER - TY - JOUR AU - Moriceau, G. AU - Hugo, W. AU - Hong, A. AU - Shi, H. AU - Kong, X. AU - Yu, C. C. PY - 2015 DA - 2015// TI - Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2014.11.018 DO - 10.1016/j.ccell.2014.11.018 ID - Moriceau2015 ER - TY - JOUR AU - Hugo, W. AU - Shi, H. AU - Sun, L. AU - Piva, M. AU - Song, C. AU - Kong, X. PY - 2015 DA - 2015// TI - Non-genomic and immune evolution of melanoma acquiring MAPKi resistance JO - Cell VL - 162 UR - https://doi.org/10.1016/j.cell.2015.07.061 DO - 10.1016/j.cell.2015.07.061 ID - Hugo2015 ER - TY - JOUR AU - Emmons, M. F. AU - Faiao-Flores, F. AU - Smalley, K. S. PY - 2016 DA - 2016// TI - The role of phenotypic plasticity in the escape of cancer cells from targeted therapy JO - Biochem Pharmacol VL - 122 UR - https://doi.org/10.1016/j.bcp.2016.06.014 DO - 10.1016/j.bcp.2016.06.014 ID - Emmons2016 ER - TY - JOUR AU - Lito, P. AU - Rosen, N. AU - Solit, D. B. PY - 2013 DA - 2013// TI - Tumor adaptation and resistance to RAF inhibitors JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3392 DO - 10.1038/nm.3392 ID - Lito2013 ER - TY - JOUR AU - Carey, T. E. AU - Takahashi, T. AU - Resnick, L. A. AU - Oettgen, H. F. AU - Old, L. J. PY - 1976 DA - 1976// TI - Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells JO - Proc Natl Acad Sci U S A VL - 73 UR - https://doi.org/10.1073/pnas.73.9.3278 DO - 10.1073/pnas.73.9.3278 ID - Carey1976 ER - TY - JOUR AU - Fogh, J. AU - Fogh, J. M. AU - Orfeo, T. PY - 1977 DA - 1977// TI - One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice JO - J Natl Cancer Inst VL - 59 UR - https://doi.org/10.1093/jnci/59.1.221 DO - 10.1093/jnci/59.1.221 ID - Fogh1977 ER - TY - JOUR AU - Giard, D. J. AU - Aaronson, S. A. AU - Todaro, G. J. AU - Arnstein, P. AU - Kersey, J. H. AU - Dosik, H. PY - 1973 DA - 1973// TI - In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors JO - J Natl Cancer Inst VL - 51 UR - https://doi.org/10.1093/jnci/51.5.1417 DO - 10.1093/jnci/51.5.1417 ID - Giard1973 ER - TY - JOUR AU - Xing, F. AU - Persaud, Y. AU - Pratilas, C. A. AU - Taylor, B. S. AU - Janakiraman, M. AU - She, Q. B. PY - 2012 DA - 2012// TI - Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.250 DO - 10.1038/onc.2011.250 ID - Xing2012 ER - TY - JOUR AU - Langmead, B. AU - Salzberg, S. L. PY - 2012 DA - 2012// TI - Fast gapped-read alignment with bowtie 2 JO - Nat Methods VL - 9 UR - https://doi.org/10.1038/nmeth.1923 DO - 10.1038/nmeth.1923 ID - Langmead2012 ER - TY - JOUR AU - Trapnell, C. AU - Roberts, A. AU - Goff, L. AU - Pertea, G. AU - Kim, D. AU - Kelley, D. R. PY - 2012 DA - 2012// TI - Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and cufflinks JO - Nat Protoc VL - 7 UR - https://doi.org/10.1038/nprot.2012.016 DO - 10.1038/nprot.2012.016 ID - Trapnell2012 ER - TY - JOUR AU - Robinson, M. D. AU - McCarthy, D. J. AU - Smyth, G. K. PY - 2010 DA - 2010// TI - edgeR: a Bioconductor package for differential expression analysis of digital gene expression data JO - Bioinformatics VL - 26 UR - https://doi.org/10.1093/bioinformatics/btp616 DO - 10.1093/bioinformatics/btp616 ID - Robinson2010 ER - TY - JOUR AU - Mootha, V. K. AU - Lindgren, C. M. AU - Eriksson, K. F. AU - Subramanian, A. AU - Sihag, S. AU - Lehar, J. PY - 2003 DA - 2003// TI - PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes JO - Nat Genet VL - 34 UR - https://doi.org/10.1038/ng1180 DO - 10.1038/ng1180 ID - Mootha2003 ER - TY - JOUR AU - Subramanian, A. AU - Tamayo, P. AU - Mootha, V. K. AU - Mukherjee, S. AU - Ebert, B. L. AU - Gillette, M. A. PY - 2005 DA - 2005// TI - Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles JO - Proc Natl Acad Sci U S A. VL - 102 UR - https://doi.org/10.1073/pnas.0506580102 DO - 10.1073/pnas.0506580102 ID - Subramanian2005 ER - TY - JOUR AU - Friedmann, P. S. AU - Gilchrest, B. A. PY - 1987 DA - 1987// TI - Ultraviolet radiation directly induces pigment production by cultured human melanocytes JO - J Cell Physiol VL - 133 UR - https://doi.org/10.1002/jcp.1041330111 DO - 10.1002/jcp.1041330111 ID - Friedmann1987 ER - TY - STD TI - Liu F, Singh A, Yang Z, Garcia A, Kong Y, Meyskens FL, Jr. MiTF links Erk1/2 kinase and p21 CIP1/WAF1 activation after UVC radiation in normal human melanocytes and melanoma cells. Mol Cancer 2010; 9:214. doi:https://doi.org/10.1186/1476-4598-9-214. ID - ref29 ER - TY - JOUR AU - Bradford, M. M. PY - 1976 DA - 1976// TI - A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding JO - Anal Biochem VL - 72 UR - https://doi.org/10.1016/0003-2697(76)90527-3 DO - 10.1016/0003-2697(76)90527-3 ID - Bradford1976 ER - TY - JOUR AU - Sondergaard, J. N. AU - Nazarian, R. AU - Wang, Q. AU - Guo, D. AU - Hsueh, T. AU - Mok, S. PY - 2010 DA - 2010// TI - Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032 JO - J Transl Med VL - 8 UR - https://doi.org/10.1186/1479-5876-8-39 DO - 10.1186/1479-5876-8-39 ID - Sondergaard2010 ER - TY - STD TI - Filipp FV. Epioncogenes in cancer—identification of epigenomic and transcriptomic cooperation-networks by multi-omics integration of ChIP-Seq and RNA-Seq data. Syst Biol. Meth Mol Biol. 2019;1800:101–21. ID - ref32 ER - TY - JOUR AU - Shain, A. H. AU - Bastian, B. C. PY - 2016 DA - 2016// TI - From melanocytes to melanomas JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.37 DO - 10.1038/nrc.2016.37 ID - Shain2016 ER - TY - JOUR AU - Tiffen, J. AU - Wilson, S. AU - Gallagher, S. J. AU - Hersey, P. AU - Filipp, F. V. PY - 2016 DA - 2016// TI - Somatic copy number amplification and Hyperactivating somatic mutations of EZH2 correlate with DNA methylation and drive epigenetic silencing of genes involved in tumor suppression and immune responses in melanoma JO - Neoplasia VL - 18 UR - https://doi.org/10.1016/j.neo.2016.01.003 DO - 10.1016/j.neo.2016.01.003 ID - Tiffen2016 ER - TY - JOUR AU - Lito, P. AU - Pratilas, C. A. AU - Joseph, E. W. AU - Tadi, M. AU - Halilovic, E. AU - Zubrowski, M. PY - 2012 DA - 2012// TI - Relief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomas JO - Cancer Cell VL - 22 UR - https://doi.org/10.1016/j.ccr.2012.10.009 DO - 10.1016/j.ccr.2012.10.009 ID - Lito2012 ER - TY - JOUR AU - Yao, Z. AU - Torres, N. M. AU - Tao, A. AU - Gao, Y. AU - Luo, L. AU - Li, Q. PY - 2015 DA - 2015// TI - BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition JO - Cancer Cell VL - 28 UR - https://doi.org/10.1016/j.ccell.2015.08.001 DO - 10.1016/j.ccell.2015.08.001 ID - Yao2015 ER - TY - JOUR AU - Wagle, N. AU - Van Allen, E. M. AU - Treacy, D. J. AU - Frederick, D. T. AU - Cooper, Z. A. AU - Taylor-Weiner, A. PY - 2014 DA - 2014// TI - MAP kinase pathway alterations in BRAF-mutant melanoma patients with acquired resistance to combined RAF/MEK inhibition JO - Cancer Discov VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0631 DO - 10.1158/2159-8290.CD-13-0631 ID - Wagle2014 ER - TY - JOUR AU - Shi, H. AU - Hugo, W. AU - Kong, X. AU - Hong, A. AU - Koya, R. C. AU - Moriceau, G. PY - 2014 DA - 2014// TI - Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy JO - Cancer Discov. VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-13-0642 DO - 10.1158/2159-8290.CD-13-0642 ID - Shi2014 ER - TY - JOUR AU - Johnson, D. B. AU - Menzies, A. M. AU - Zimmer, L. AU - Eroglu, Z. AU - Ye, F. AU - Zhao, S. PY - 2015 DA - 2015// TI - Acquired BRAF inhibitor resistance: a multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms JO - Eur J Cancer VL - 51 UR - https://doi.org/10.1016/j.ejca.2015.08.022 DO - 10.1016/j.ejca.2015.08.022 ID - Johnson2015 ER - TY - STD TI - Filipp FV. Precision medicine driven by cancer systems biology. Cancer Metastasis Rev. 2017;36(1):91–108.. https://doi.org/10.1007/s10555-017-9662-4. ID - ref40 ER - TY - JOUR AU - Johannessen, C. M. AU - Johnson, L. A. AU - Piccioni, F. AU - Townes, A. AU - Frederick, D. T. AU - Donahue, M. K. PY - 2013 DA - 2013// TI - A melanocyte lineage program confers resistance to MAP kinase pathway inhibition JO - Nature VL - 504 UR - https://doi.org/10.1038/nature12688 DO - 10.1038/nature12688 ID - Johannessen2013 ER - TY - STD TI - Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436(7047):117–22. https://doi.org/10.1038/nature03664. ID - ref42 ER - TY - JOUR AU - Hernandez-Davies, J. E. AU - Tran, T. Q. AU - Reid, M. A. AU - Rosales, K. R. AU - Lowman, X. H. AU - Pan, M. PY - 2015 DA - 2015// TI - Vemurafenib resistance reprograms melanoma cells towards glutamine dependence JO - J Transl Med VL - 13 UR - https://doi.org/10.1186/s12967-015-0581-2 DO - 10.1186/s12967-015-0581-2 ID - Hernandez-Davies2015 ER - TY - JOUR AU - Edwards, L. AU - Gupta, R. AU - Filipp, F. V. PY - 2016 DA - 2016// TI - Hypermutation of DPYD deregulates pyrimidine metabolism and promotes malignant progression JO - Mol Cancer Res VL - 14 UR - https://doi.org/10.1158/1541-7786.MCR-15-0403 DO - 10.1158/1541-7786.MCR-15-0403 ID - Edwards2016 ER - TY - JOUR AU - Yang, J. Y. AU - Hung, M. C. PY - 2009 DA - 2009// TI - A new fork for clinical application: targeting forkhead transcription factors in cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-0124 DO - 10.1158/1078-0432.CCR-08-0124 ID - Yang2009 ER - TY - JOUR AU - Gomis, R. R. AU - Alarcon, C. AU - He, W. AU - Wang, Q. AU - Seoane, J. AU - Lash, A. PY - 2006 DA - 2006// TI - A FoxO-Smad synexpression group in human keratinocytes JO - Proc Natl Acad Sci U S A. VL - 103 UR - https://doi.org/10.1073/pnas.0605333103 DO - 10.1073/pnas.0605333103 ID - Gomis2006 ER - TY - JOUR AU - Lasfar, A. AU - Cohen-Solal, K. A. PY - 2010 DA - 2010// TI - Resistance to transforming growth factor beta-mediated tumor suppression in melanoma: are multiple mechanisms in place? JO - Carcinogenesis VL - 31 UR - https://doi.org/10.1093/carcin/bgq155 DO - 10.1093/carcin/bgq155 ID - Lasfar2010 ER - TY - JOUR AU - Kong, P. Z. AU - Li, G. M. AU - Tian, Y. AU - Song, B. AU - Shi, R. PY - 2016 DA - 2016// TI - Decreased expression of FOXF2 as new predictor of poor prognosis in stage I non-small cell lung cancer JO - Oncotarget VL - 7 ID - Kong2016 ER - TY - JOUR AU - Abel, E. V. AU - Aplin, A. E. PY - 2010 DA - 2010// TI - FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3139 DO - 10.1158/0008-5472.CAN-09-3139 ID - Abel2010 ER - TY - JOUR AU - Abel, E. V. AU - Basile, K. J. AU - Kugel, C. H. AU - Witkiewicz, A. K. AU - Le, K. AU - Amaravadi, R. K. PY - 2013 DA - 2013// TI - Melanoma adapts to RAF/MEK inhibitors through FOXD3-mediated upregulation of ERBB3 JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI65780 DO - 10.1172/JCI65780 ID - Abel2013 ER - TY - STD TI - Zecena H, Tveit D, Wang Z, Farhat A, Panchal P, Liu J, et al. Systems biology analysis of mitogen activated protein kinase inhibitor resistance in malignant melanoma bioRxiv; 2017. https://doi.org/10.1101/231142. ID - ref51 ER -